Twist Bioscience officer proposes $385K share sale
The notice also records three common-share sales by Adam Laponis during the prior three months, dated July 9, August 21 and October 2, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Twist Bioscience Corp (TWST) is the issuer named in a Rule 144 notice by officer Adam Laponis for a proposed sale of 2,462 common shares, with an aggregate market value of $384,822.66. The shares are listed as acquired through restricted stock vesting on October 8, 2026. The remarks state that the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
vested equity award distribution financial
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.